Join our trial

We have two active clinical studies investigating the use of our Stentrode device to restore motor control over digital devices. The study involves having a device placed via a procedure using a catheter inserted through the jugular vein. The trial then assesses how you can use the device to control Apple devices to improve your ability to engage with the digital world.

As I can no longer move my hands, I can ask my wife to feed me, bring me water, help me dress, move my pillows and other activities. It's a great relief to know that, if my voice goes, I will be able to text her my needs, and can continue to tell her how much I love and appreciate her.

Synchron trial participant
United States

INTENT

ClinicalTrials.gov # NCT07543367 (opens in new tab)

Eligibility: Severe bilateral upper limb motor weakness due to ALS.

Australia

FOCUS

ClinicalTrials.gov # NCT07533903 (opens in new tab)

Eligibility: Severe bilateral upper limb motor weakness due to a range of motor impairment conditions.

Mount Sinai Hospital

New York, NY

University at Buffalo Neurosurgery

Buffalo, NY

UT Southwestern Medical Center

Dallas, TX

Mayo Clinic

Jacksonville, FL

Pending

UPMC Presbyterian

Pittsburgh, PA

Royal Melbourne Hospital

Melbourne, VIC

Liverpool Hospital

Sydney, NSW

Pending

The Alfred Hospital

Melbourne, VIC

Royal Brisbane and Women's Hospital

Brisbane, QLD

Patients with tetraplegia face unique and important health challenges due to the loss of autonomy that can occur with motor impairment. Implantable MNP BCI's hold promise to restore continuous autonomy through the restoration of motor intent transmission to control the digital environment.

David Putrino, Director of Rehabilitation Innovation, Icahn School of Medicine at Mount Sinai